In February, SmarterCompliance newsletter published a detailed six page analysis of FDA’s action plan to revise the 510(k) medical device submission, approval, and post-marketing processes. Subscribers also received… Continue reading at ComplianceZen.com →
From the Blog
Lowering Liability Risks with Supplier Qualification
FDA Compliance Training – Free Consulting?
From the NIH – Biotechnology Landscape 2020
FDA Forecast for 2012
From the PCP Council Science Symposium
Client Success Stories
“John Avellanet was extremely helpful in assisting us to develop records and information management policies and records retention schedules that matched our FDA requirements and our resource capabilities. In addition, he managed our project expectations well and kept us on track and on budget.”
- Chih-Wu Chang, Senior Quality Manager, San Diego, California
